Kolexia
Turpin Justine
Gastro-entérologie
Centre Hospitalier de Abbeville
Abbeville, France
43 Activités
3 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladies inflammatoires intestinales Maladie de Crohn Adénocarcinome Réaction au site d'injection Douleur chronique Perte de poids Diarrhée Fistule rectale Abcès

Industries

Abbvie
14 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
8 collaboration(s)
Dernière en 2023
Servier
4 collaboration(s)
Dernière en 2021
Amgen
4 collaboration(s)
Dernière en 2023

Dernières activités

Daily practices in chemotherapy for advanced gastric or gastroesophageal junction adenocarcinoma: METESTOMAC French prospective cohort.
Cancer medicine   16 novembre 2022
Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon cancer from the PRODIGE 34-FFCD randomized trial.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   14 septembre 2022
Positive histologic margins is a risk factor of recurrence after ileocaecal resection in Crohn's disease.
Clinics and research in hepatology and gastroenterology   14 novembre 2020
No Benefit of Concomitant Immunomodulator Therapy on Efficacy of Biologics That Are Not Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases: A Meta-analysis.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association   03 juillet 2020
Inflammatory bowel disease symptoms at the time of anal fistula lead to the diagnosis of Crohn's disease.
Clinics and research in hepatology and gastroenterology   23 avril 2020
Complete Endoscopic Healing Associated With Better Outcomes Than Partial Endoscopic Healing in Patients With Crohn's Disease.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association   16 novembre 2019
Premedication as primary prophylaxis does not influence the risk of acute infliximab infusion reactions in immune-mediated inflammatory diseases: A systematic review and meta-analysis.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   13 décembre 2018
{{person.lastact8.name}}
{{person.lastact8.jour}}   {{person.lastact8.date}}
{{person.lastact9.name}}
{{person.lastact9.jour}}   {{person.lastact9.date}}
{{person.lastact10.name}}
{{person.lastact10.jour}}   {{person.lastact10.date}}